The evolving landscape of mucinous cystic neoplasms (MCNs) management represents a compelling intersection of clinical innovation, market dynamics, and healthcare investment opportunities. As healthcare systems worldwide grapple with the complexities of rare pancreatic disorders, MCNs have emerged as a focal point for understanding how specialized medical markets adapt to...